Crinetics Pharmaceuticals Announces January 2026 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2026, the Compensation Committee of the ...
Nasdaq

Nasdaq Welcomes 142 IPOs in the First Half of 2025

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) announced today that in the first half of 2025, it welcomed 142 listings (IPOs), raising a total of $19.2 billion. A total of 83 ...
Nasdaq

Nasdaq Extends Over a Decade of Listings Leadership as U.S. IPO Market Rebounds

Nasdaq once again led the U.S. listings market in 2025, welcoming the largest exchange transfer in history and the biggest IPO of the year. This year marked the exchange’s highest volume for capital ...
Nasdaq

Nasdaq Maintains Over a Decade of Listings Leadership in 2025

NEW YORK, December 18, 2025 -- Nasdaq (Nasdaq: NDAQ) announced today that in 2025 it raised a total of $46.65 billion from new listings, marking the strongest year for capital raise since 2021. In ...
Nasdaq

HOTEL101 PROGRESSES TOWARDS NASDAQ LISTING

SINGAPORE, June 2, 2025 /PRNewswire/ -- Hotel101 Global Holdings Corp. ("Hotel101" or "HBNB") and JVSPAC Acquisition Corp. (NASDAQ: JVSA) ("JVSPAC") announced today that the United States Securities ...

Nasdaq 2025 | Leading with Clarity

In 2025, the Nasdaq‑100® celebrated its 40th anniversary, cementing its role as the world’s leading large‑cap growth index. With over $500B in exchange‑traded products and availability across six ...